Tyler S. Finn

762 total citations
10 papers, 595 citations indexed

About

Tyler S. Finn is a scholar working on Infectious Diseases, Surgery and Virology. According to data from OpenAlex, Tyler S. Finn has authored 10 papers receiving a total of 595 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Infectious Diseases, 3 papers in Surgery and 3 papers in Virology. Recurrent topics in Tyler S. Finn's work include HIV Research and Treatment (3 papers), HIV/AIDS Research and Interventions (3 papers) and HIV/AIDS drug development and treatment (3 papers). Tyler S. Finn is often cited by papers focused on HIV Research and Treatment (3 papers), HIV/AIDS Research and Interventions (3 papers) and HIV/AIDS drug development and treatment (3 papers). Tyler S. Finn collaborates with scholars based in United States, Australia and Puerto Rico. Tyler S. Finn's co-authors include Erin Jensen, Kamal M.F. Itani, Murray A. Abramson, Samir S. Awad, Samuel E. Wilson, Ralph Buttyan, Jin T. E. Lim, Li Han, Edward K. Han and Gary A. Piazza and has published in prestigious journals such as New England Journal of Medicine, Antimicrobial Agents and Chemotherapy and Biochemical Pharmacology.

In The Last Decade

Tyler S. Finn

10 papers receiving 572 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tyler S. Finn United States	9	234	155	133	132	107	10	595
Thao Doan United States	13	77 0.3×	65 0.4×	126 0.9×	47 0.4×	18 0.2×	35	543
Kersti Oselin Estonia	15	72 0.3×	373 2.4×	114 0.9×	175 1.3×	13 0.1×	41	721
Michael Heifets United States	15	242 1.0×	42 0.3×	195 1.5×	31 0.2×	23 0.2×	25	797
Christine L. E. Siezen Netherlands	16	136 0.6×	96 0.6×	98 0.7×	94 0.7×	22 0.2×	19	810
C. Mel Wilcox United States	14	324 1.4×	89 0.6×	75 0.6×	120 0.9×	45 0.4×	27	559
Seok Hwee Koo Singapore	16	106 0.5×	119 0.8×	68 0.5×	49 0.4×	81 0.8×	49	702
Susan Raber United States	14	40 0.2×	82 0.5×	132 1.0×	283 2.1×	42 0.4×	33	628
Evan M. Cadoff United States	11	116 0.5×	66 0.4×	104 0.8×	22 0.2×	9 0.1×	22	530
Emmanuel Chigutsa United States	15	119 0.5×	118 0.8×	526 4.0×	180 1.4×	7 0.1×	28	857
Damien Simoneau France	12	103 0.4×	48 0.3×	120 0.9×	79 0.6×	36 0.3×	17	644

Countries citing papers authored by Tyler S. Finn

Since Specialization

Citations

This map shows the geographic impact of Tyler S. Finn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tyler S. Finn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tyler S. Finn more than expected).

Fields of papers citing papers by Tyler S. Finn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tyler S. Finn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tyler S. Finn. The network helps show where Tyler S. Finn may publish in the future.

Co-authorship network of co-authors of Tyler S. Finn

This figure shows the co-authorship network connecting the top 25 collaborators of Tyler S. Finn. A scholar is included among the top collaborators of Tyler S. Finn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tyler S. Finn. Tyler S. Finn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Russell, Kevin L., Richard Rupp, Javier O Morales-Ramirez, et al.. (2022). A phase I randomized, double-blind, placebo-controlled study to evaluate the safety, tolerability, and immunogenicity of a live-attenuated quadrivalent dengue vaccine in flavivirus-naïve and flavivirus-experienced healthy adults. Human Vaccines & Immunotherapeutics. 18(5). 2046960–2046960. 20 indexed citations

Finn, Tyler S.. (2018). Qualified Immunity Formalism: 'Clearly Established Law' and the Right to Record Police Activity. SSRN Electronic Journal. 1 indexed citations

Manoff, Susan B., Jason Martin, David Radley, et al.. (2018). Immunogenicity and safety of an investigational tetravalent recombinant subunit vaccine for dengue: results of a Phase I randomized clinical trial in flavivirus-naïve adults. Human Vaccines & Immunotherapeutics. 15(9). 2195–2204. 52 indexed citations

Itani, Kamal M.F., Erin Jensen, Tyler S. Finn, Joanne E. Tomassini, & Murray A. Abramson. (2008). Effect of Body Mass Index and Ertapenem versus Cefotetan Prophylaxis on Surgical Site Infection in Elective Colorectal Surgery. Surgical Infections. 9(2). 131–137. 42 indexed citations

Itani, Kamal M.F., Samuel E. Wilson, Samir S. Awad, et al.. (2007). Polyethylene glycol versus sodium phosphate mechanical bowel preparation in elective colorectal surgery. The American Journal of Surgery. 193(2). 190–194. 27 indexed citations

Itani, Kamal M.F., Samuel E. Wilson, Samir S. Awad, et al.. (2006). Ertapenem versus Cefotetan Prophylaxis in Elective Colorectal Surgery. New England Journal of Medicine. 355(25). 2640–2651. 205 indexed citations

Haas, David W., Benjamin Johnson, Janet Nicotera, et al.. (2003). Effects of Ritonavir on Indinavir Pharmacokinetics in Cerebrospinal Fluid and Plasma. Antimicrobial Agents and Chemotherapy. 47(7). 2131–2137. 35 indexed citations

Young, Benjamin, Margaret A. Fischl, Tyler S. Finn, et al.. (2002). Open-Label Study of a Twice-Daily Indinavir 800-mg/Ritonavir 100-mg Regimen in Protease Inhibitor–Naive HIV-Infected Adults. JAIDS Journal of Acquired Immune Deficiency Syndromes. 31(5). 478–482. 25 indexed citations

Katner, Harold, Dávid Paár, Jeffrey P. Nadler, et al.. (2002). Open-Label Study of a Twice-Daily Indinavir 800-mg/Ritonavir 200-mg Regimen in HIV-Infected Adults Failing a Protease Inhibitor Regimen. JAIDS Journal of Acquired Immune Deficiency Syndromes. 31(5). 483–487. 8 indexed citations

10.

Lim, Jin T. E., Gary A. Piazza, Edward K. Han, et al.. (1999). Sulindac derivatives inhibit growth and induce apoptosis in human prostate cancer cell lines. Biochemical Pharmacology. 58(7). 1097–1107. 180 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact